ArriVent BioPharma, Inc. Common Stock (AVBP) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 46.11M | 38.82M | 38.32M | 33.62M | 66.77M | 23.7M | 24.23M | 25.7M | 20.67M | 23.12M | 16.72M | 22.58M | 12.17M | 10.44M | 7.35M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 8.49M | 6.65M | 6.15M | 5.9M | 5.48M | 3.54M | 4.14M | 3.92M | 3.7M | 3.11M | 2.44M | 2.23M | 1.94M | 1.79M | 1.5M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 37.62M | 32.17M | 32.17M | 27.72M | 61.29M | 20.16M | 20.09M | 21.78M | 16.98M | 20.01M | 14.28M | 20.36M | 10.24M | 8.65M | 5.85M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -46.11M | -38.82M | -38.32M | -33.62M | -66.77M | -23.7M | -24.23M | -25.7M | -20.67M | -23.12M | -16.72M | -22.58M | -12.17M | -10.44M | -7.35M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 30.94% | -63.78% | -58.12% | -30.84% | -222.98% | -2.54% | -44.96% | -13.78% | -69.85% | -121.39% | - | - | -65.65% | - | - |
| EBITDA | -46.11M | -38.82M | -34.98M | -31.4M | -66.77M | -23.7M | -24.23M | -25.7M | -20.67M | -23.12M | -16.72M | -22.58M | 0 | 0 | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 30.94% | -63.78% | -44.35% | -22.19% | -222.98% | -2.54% | -44.96% | -13.78% | - | - | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.17M | 10.44M | 7.35M |
| EBIT | -46.11M | -38.82M | -34.98M | -31.4M | -66.77M | -23.7M | -24.23M | -25.7M | -20.67M | -23.12M | -16.72M | -22.58M | -12.17M | -10.44M | -7.35M |
| Net Interest Income | 2.79M | 3.28M | 3.34M | 2.22M | 2.38M | 3.07M | 3.67M | 3.82M | 3.26M | 1.93M | 2.31M | 1.02M | 0 | 0 | 0 |
| Interest Income | 2.79M | 3.28M | 3.34M | 2.22M | 2.38M | 3.07M | 3.67M | 3.82M | 3.26M | 1.93M | 2.31M | 1.02M | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.79M | 3.28M | 3.34M | 2.22M | 2.38M | 3.07M | 3.67M | 3.82M | 3.26M | 1.93M | 2.31M | 1.02M | 0 | 0 | 0 |
| Pretax Income | -43.32M | -35.54M | -34.98M | -31.4M | -64.39M | -20.63M | -20.56M | -21.87M | -17.42M | -21.19M | -14.4M | -21.57M | -12.17M | -10.44M | -7.35M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -43.32M | -35.54M | -34.98M | -31.4M | -64.39M | -20.63M | -20.56M | -21.87M | -17.42M | -21.19M | -14.4M | -21.57M | -12.17M | -10.44M | -7.35M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 32.72% | -72.27% | -70.09% | -43.54% | -269.68% | 2.64% | -42.8% | -1.42% | -43.09% | -102.96% | - | - | -65.65% | - | - |
| Net Income (Continuing) | -43.32M | -35.54M | -34.98M | -31.4M | -64.39M | -20.63M | -20.56M | -21.87M | -17.42M | -21.19M | -14.4M | -21.57M | -12.17M | -10.44M | -7.35M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.96 | -0.84 | -0.83 | -0.90 | -1.90 | -0.61 | -0.61 | -0.65 | -0.52 | -0.63 | -0.43 | -0.64 | -0.36 | -0.31 | -5.76 |
| EPS Growth % | 49.47% | -37.7% | -36.07% | -38.46% | -265.38% | 3.17% | -41.86% | -1.56% | -44.44% | -103.23% | - | - | 93.75% | - | - |
| EPS (Basic) | -0.96 | -0.84 | -0.83 | -0.90 | -1.90 | -0.61 | -0.61 | -0.65 | -0.52 | -0.63 | -0.43 | -0.64 | -0.36 | -0.31 | -5.76 |
| Diluted Shares Outstanding | 45.07M | 38.46M | 41.91M | 35.01M | 33.9M | 33.58M | 33.58M | 33.51M | 33.49M | 33.49M | 33.49M | 33.49M | 33.49M | 33.49M | 1.28M |
| Basic Shares Outstanding | 45.07M | 38.46M | 41.91M | 35.01M | 33.9M | 33.58M | 33.58M | 33.51M | 33.49M | 33.49M | 33.49M | 33.49M | 33.49M | 33.49M | 1.28M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |